• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • GEFITINIB TEVA
    / SLE


    Active Ingredient
    Gefitinib 250 mg

    Status in Israel
    RX

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft

    Film Coated Tablets

    30

    partial basket chart

    Related information


    Dosage

    The recommended dosage is one 250 mg tablet once a day, with or without food.


    Indications

    Treatment of  adult patients with locally advanced or metastatic Non‐small cell lung cancer (NSCLC) with activating mutations of EGFR‐TK.


    Contra-Indications

    Hypersensitivity to the active substance or any of its excipients.
    Lactation.


    Manufacturer
    Teva Pharmaceutical Industries Ltd, Israel
    Licence holder
    CLOSE